Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress
Share Facebook Twitter LinkedIn Pinterest Email Helio Castroneves joins Nick Wright, Chris Broussard, and Kevin Wildes to discuss who his biggest rival is entering the Indy 500.
